BioCryst Pharmaceuticals, Inc.
BCRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$89 | -$227 | -$247 | -$184 |
| Dep. & Amort. | $1 | $2 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $65 | $56 | $45 | $35 |
| Change in WC | -$87 | -$32 | -$59 | $8 |
| Other Non-Cash | $57 | $107 | $98 | -$2 |
| Operating Cash Flow | -$52 | -$95 | -$162 | -$142 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$267 | -$514 | -$244 | -$10 |
| Inv. Sales/Matur. | $320 | $385 | $117 | $28 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $53 | -$131 | -$128 | $16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2 | $58 | $73 | $294 |
| Stock Issued | $0 | $0 | $0 | $50 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | -$26 | $15 | $16 |
| Financing Cash Flow | -$6 | $32 | $88 | $360 |
| Forex Effect | -$1 | $0 | $1 | $0 |
| Net Chg. in Cash | -$6 | -$194 | -$201 | $233 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $112 | $306 | $508 | $274 |
| End Cash | $106 | $112 | $306 | $508 |
| Free Cash Flow | -$53 | -$97 | -$163 | -$145 |